| 000 | 01379 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515122918.0 | ||
| 264 | 0 | _c20080904 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e3282fa75ce _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStary, Georg | |
| 245 | 0 | 0 |
_aComplete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cJun 2008 |
||
| 300 |
_a1232-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aCastleman Disease _xcomplications |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aThalidomide _xtherapeutic use |
| 700 | 1 | _aKohrgruber, Norbert | |
| 700 | 1 | _aHerneth, Andreas M | |
| 700 | 1 | _aGaiger, Alexander | |
| 700 | 1 | _aStingl, Georg | |
| 700 | 1 | _aRieger, Armin | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 22 _gno. 10 _gp. 1232-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e3282fa75ce _zAvailable from publisher's website |
| 999 |
_c18017876 _d18017876 |
||